Latest news with #NokiaOyj
Yahoo
15-05-2025
- Business
- Yahoo
Howard Marks Exits Infinera Corp, Impacting Portfolio by -3.41%
Howard Marks (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2025, providing insights into his investment moves during this period. As the Chairman of Oaktree Capital Management LP, Marks has been instrumental in guiding the firm since its inception in 1995. Known for his adherence to a disciplined investment philosophy, Marks focuses on less efficient markets and alternative investments, with a strong emphasis on debt, preferred stocks, and convertible bonds. His strategic decisions are closely watched by value investors seeking to emulate his success. Howard Marks (Trades, Portfolio) added a total of 9 stocks to his portfolio, with notable additions including: The most significant addition was Nokia Oyj (NYSE:NOK), with 18,752,227 shares, accounting for 2.3% of the portfolio and a total value of $98.82 million. The second largest addition was TransAlta Corp (NYSE:TAC), consisting of 5,585,253 shares, representing approximately 1.21% of the portfolio, with a total value of $52.12 million. The third largest addition was Grab Holdings Ltd (NASDAQ:GRAB), with 10,275,995 shares, accounting for 1.08% of the portfolio and a total value of $46.55 million. Howard Marks (Trades, Portfolio) also increased stakes in a total of 5 stocks, among them: The most notable increase was Barrick Mining Corp (NYSE:B), with an additional 1,501,595 shares, bringing the total to 2,516,658 shares. This adjustment represents a significant 147.93% increase in share count, a 0.68% impact on the current portfolio, with a total value of $48.92 million. The second largest increase was Cemex SAB de CV (NYSE:CX), with an additional 4,794,697 shares, bringing the total to 19,383,729. This adjustment represents a significant 32.87% increase in share count, with a total value of $108.74 million. Howard Marks (Trades, Portfolio) completely exited 12 holdings in the first quarter of 2025, as detailed below: Infinera Corp (INFN): Howard Marks (Trades, Portfolio) sold all 25,175,384 shares, resulting in a -3.41% impact on the portfolio. Sunrise Communications AG (NASDAQ:SNRE): Howard Marks (Trades, Portfolio) liquidated all 1,440,836 shares, causing a -1.28% impact on the portfolio. Howard Marks (Trades, Portfolio) also reduced positions in 16 stocks. The most significant changes include: Reduced Expand Energy Corp (NASDAQ:EXE) by 1,375,000 shares, resulting in a -19.82% decrease in shares and a -2.82% impact on the portfolio. The stock traded at an average price of $104.03 during the quarter and has returned 9.07% over the past 3 months and 15.41% year-to-date. Reduced California Resources Corp (NYSE:CRC) by 670,000 shares, resulting in a -32.73% reduction in shares and a -0.72% impact on the portfolio. The stock traded at an average price of $47.45 during the quarter and has returned -10.62% over the past 3 months and -16.93% year-to-date. At the first quarter of 2025, Howard Marks (Trades, Portfolio)'s portfolio included 55 stocks. The top holdings included 15.45% in TORM PLC (NASDAQ:TRMD), 14.43% in Expand Energy Corp (NASDAQ:EXE), 8.6% in Garrett Motion Inc (NASDAQ:GTX), 5.99% in Sitio Royalties Corp (NYSE:STR), and 4.73% in Anglogold Ashanti PLC (NYSE:AU). The holdings are mainly concentrated in 11 industries: Energy, Basic Materials, Consumer Cyclical, Financial Services, Communication Services, Technology, Real Estate, Healthcare, Utilities, Consumer Defensive, and Industrials. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
&w=3840&q=100)
Business Standard
28-04-2025
- Business
- Business Standard
Will AI help Denmark avoid its Nokia moment as Ozempic boom starts fading?
Remember Nokia Oyj, Finland's economic miracle that turned to dust? The Danes do. Their own mini-boom of recent years has been largely fueled by one firm, Ozempic maker Novo Nordisk A/S, whose diabetes and weight-loss medications are under competitive assault from US rival Eli Lilly & Co. Novo's share price has halved in six months; it's given up its crown of Europe's most valuable firm to SAP SE. This reflects deflating hype rather than a crisis. Novo sales are still forecast to grow at double-digit rates this year, according to Bloomberg Intelligence, with Denmark's economy set to grow above the European average. But throw in the risk of a Trump tariff war over Greenland, and you can see why there's more fear than there used to be of a Nokia moment in a small export-reliant country of 6 million whose multinationals like AP Moller Maersk A/S and Vestas Wind Systems A/S punch well above their weight. 'I'm starting to get worried,' says Martin Jes Iversen, a professor at the Copenhagen Business School, whose research shows a small group of very big firms — including Novo — has become critical to the economy. Novo's disproportionate share of profits and research spending was also highlighted by University of Virginia Professor Herman Mark Schwartz in a 2023 essay called The Nokia Risk, which warned that Denmark lacked the kind of home-grown artificial-intelligence firms that might drive more disruptive innovation. Hence why it's encouraging to see the spoils of Denmark's Ozempic success being reinvested in potentially more future-proof projects like the recently unveiled supercomputer Gefion. Designed specifically for big AI projects, Gefion — named after the Norse goddess of fertility — was funded to the tune of $87 million by Novo's nonprofit foundation, the firm's majority voting shareholder, in partnership with Nvidia Corp., which supplied the chips. Aside from the optics of spreading the Ozempic wealth around, this supercomputer opens up potential for AI research and startups in Denmark and Europe, which is desperate to attract talent and reverse years of disappointing growth. One startup, used Gefion as part of a pilot access scheme to crunch data for tech that helps nurses monitor patients and cut workload; Chief Executive Officer Mikkel Wad Thorsen tells me computing power is a scarce resource and that Gefion is a sign Denmark is taking AI seriously. And while the potential for AI in drug discovery and eradicating disease is a much-hyped and far-off thing, it should also be noted that Gefion is part of a national plan to widen and streamline research access to Danes' health data, which was one of the recommendations in Mario Draghi's report to pull Europe out of its 'slow agony.' This isn't just for Novo's benefit — the Gefion investment was at arm's length and carries no ownership rights — but there might be positive spillover effects of this kind of research for Danish and European health care. In the short term, there isn't much to move the needle here for stressed-out shareholders of Novo and other big Danish companies. The more obvious defences that Denmark has against a trade shock are its government budget surplus and its 'flexicurity' model that combines flexibility on corporate layoffs with a secure social safety net. That and the hope that being highly exposed to pharmaceuticals isn't quite the same risk as being exposed to cellphones and paper mills, which Danske Bank economist Las Olsen says exacerbated Finland's post-Nokia blues. Longer term, though, Danes will be hoping that Gefion and other projects like the robotics hub of Odense serve as a hedge against chaos. It could mean more researchers, more tech brains and more productivity gains on a continent desperately in need of all three. Maybe building geopolitical muscle is a surprise side effect of losing weight via Ozempic.
Bloomberg
28-04-2025
- Business
- Bloomberg
Ozempic Country's AI Bet Shows It Learned Nokia's Lesson
Remember Nokia Oyj, Finland's economic miracle that turned to dust? The Danes do. Their own mini-boom of recent years has been largely fueled by one firm, Ozempic maker Novo Nordisk A/S, whose diabetes and weight-loss medications are under competitive assault from US rival Eli Lilly & Co. Novo's share price has halved in six months; it's given up its crown of Europe's most valuable firm to SAP SE. This reflects deflating hype rather than a crisis. Novo sales are still forecast to grow at double-digit rates this year, according to Bloomberg Intelligence, with Denmark's economy set to grow above the European average. But throw in the risk of a Trump tariff war over Greenland, and you can see why there's more fear than there used to be of a Nokia moment in a small export-reliant country of 6 million whose multinationals like AP Moller Maersk A/S and Vestas Wind Systems A/S punch well above their weight.
Bloomberg
24-04-2025
- Business
- Bloomberg
Nokia Says Reaching Guidance Top End ‘Challenging' With Tariffs
Nokia Oyj said that meeting the top end of its guidance for the year will be more challenging as the company grapples with the impact of tariffs. The company sees an impact of €20 million ($22.7 million) to €30 million on operating profit in the second quarter from tariffs put in place by US President Donald Trump's administration, the company said in a statement on Thursday. Espoo, Finland-based Nokia hasn't factored in an impact for tariffs on the second half of the year given the lack of visibility, it said.
Yahoo
15-04-2025
- Business
- Yahoo
Nokia Oyj (NOK): Among the Best Performing Stocks in Europe
We recently published a list of . In this article, we are going to take a look at where Nokia Oyj (NYSE:NOK) stands against other best performing European stocks to invest in. The world economy is hanging by a thread, as the macroeconomic environment consists of trade wars, retaliatory tariffs, and political unrest in Ukraine and the Middle East. It adds to economic uncertainty, with market experts offering cautious economic forecasts. According to EY, the euro area will experience a modest economic turnaround in 2025, and growth is expected to increase from 0.7% last year to 1.3% and 1.8% in 2025 and 2026, respectively. It is forecasted to simmer down to 1.4% in 2027. Among all European countries, Malta is projected to experience the highest GDP growth in 2025 at 4%. EY expects soft employment growth across Europe, driven by demographic challenges and subdued labor demand. Unemployment will likely remain at 2024 levels. While nominal wage this year will clock in higher than pre-pandemic levels, wage growth will take a hit. Central and Eastern European countries are forecasted to experience relatively higher inflation in 2025, while the overall rate remains just over 2% in the euro area. Meanwhile, German economic institutes have slashed their growth projections for 2025 to 0.1% from the previous forecast of 0.8% in September 2024. This revised estimate does not incorporate the recent tariffs levied by the US. These tariffs will be a major setback for European economies, possibly toppling them over the edge of recession for the third consecutive year. The new conservative government declared a €500 billion fund to improve infrastructure and defence and stimulate growth. The fiscal package enhances the economic outlook for 2026 and 2027. However, as the United States is feeling the pressure from high valuations and growing political instability, analysts are looking towards Europe as a better bet for stock investors. Analysts point towards Europe offering a more stable outlook, with lower stock prices, clearer policy direction, and even potential interest rate cuts on the horizon. Investors seem to be shifting their focus, partly because the threat of US tariffs on Europe, especially on automobiles, feels less uncertain now that details are clearer. There is also less exposure to tech in Europe, which is seen as a good thing right now. Europe's markets, with just 10% tech exposure in the Europe 600 compared to 30% in the broader market, look more balanced. With solid earnings, rising share buybacks, and cheaper stock valuations, investors are turning to Europe. Experts suggest that European and UK markets now have their best shot in years at outperforming the US. With that in mind, let's take a look at the best-performing stocks in Europe so far in 2025. A computer engineer engaging in coding activities in a brightly lit server room. To compile our list of the top performing European stocks this year, used the Finviz screener, applying filters for the region and a market cap of over 10 billion to identify stable European companies. Next, we applied a performance filter and selected 11 European stocks with the highest YTD share price growth as of April 11. We have also mentioned the Q4 2024 hedge fund sentiment around the holdings for further insight. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). Number of Hedge Fund Holders: 20 YTD Share Price Performance as of April 11: 11.21% Nokia Oyj (NYSE:NOK) is a Finnish provider of mobile, fixed, and cloud network solutions worldwide. The company operates through four business segments – Network Infrastructure, Mobile Networks, Cloud and Network Services, and Nokia Technologies. NOK offers services like 5G, IP and optical networks, cloud software, and licensing of its patents and brand to telecom providers, governments, and industrial enterprises. It is one of the best performing stocks in Europe. On March 3, BofA Securities analyst analyst Didier Scemama reiterated a Neutral rating on Nokia Oyj (NYSE:NOK) with a price target of €4.91, up from €4.68. Nokia's recent acquisition of American firm Infinera is expected to strengthen its financial outlook, leading BofA Securities to update their forecasts. They now expect Nokia's revenue to equal €20.8 billion in 2025, growing further in 2026 before a slight dip in 2027. Nokia Oyj (NYSE:NOK) concluded its share buyback program on April 2, 2025, which was initiated in November 2024 to help offset the dilution from its Infinera acquisition. Between late November and early April, the company repurchased 150 million shares at an average price of €4.69, for a total of roughly €703 million. Nokia plans to cancel these shares later in April. After the buyback, the company now holds just over 220 million treasury shares. According to Insider Monkey's fourth quarter database, 20 hedge funds were long Nokia Oyj (NYSE:NOK), compared to 16 funds in the preceding quarter. Richard S. Pzena's was the leading stakeholder of the company, with 83.8 million shares valued at $371.4 million. Overall, NOK ranks 11th among the 11 Top Performing European Stocks So Far In 2025. While we acknowledge the potential of European stocks, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than NOK but that trades at less than 5 times its earnings, check out our report about this . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
